Abstract:Pharmaceuticals are of concern to our planet and health as they can accumulate in the environment. The impact of these biologically active compounds on ecosystems is hard to predict, and information on their biodegradation is necessary to establish sound risk assessment. Microbial communities are promising candidates for the biodegradation of pharmaceuticals such as ibuprofen, but little is known yet about their degradation capacity of multiple micropollutants at higher concentrations (100 mg/L). In this work, microbial communities were cultivated in lab-scale membrane bioreactors (MBRs) exposed to increasing concentrations of a mixture of six micropollutants (ibuprofen, diclofenac, enalapril, caffeine, atenolol, paracetamol). Key players of biodegradation were identified using a combinatorial approach of 16S rRNA sequencing and analytics. Microbial community structure changed with increasing pharmaceutical intake (from 1 to 100 mg/L) and reached a steady-state during incubation for 7 weeks on 100 mg/L. HPLC analysis revealed a fluctuating but significant degradation (30-100%) of five pollutants (caffeine, paracetamol, ibuprofen, atenolol, enalapril) by an established and stable microbial community mainly composed of Achromobacter, Cupriavidus, Pseudomonas and Leucobacter. By using the microbial community from MBR1 as inoculum for further batch culture experiments on single micropollutants (400 mg/L substrate, respectively), different active microbial consortia were obtained for each single micropollutant. Microbial genera potentially responsible for degradation of the respective micropollutant were identified, i.e. Pseudomonas sp. and Sphingobacterium sp. for ibuprofen, caffeine and paracetamol, Sphingomonas sp. for atenolol and Klebsiella sp. for enalapril. Our study demonstrates the feasibility of cultivating stable microbial communities capable of degrading simultaneously a mixture of highly concentrated pharmaceuticals in lab-scale MBRs and the identification of microbial genera potentially responsible for the degradation of specific pollutants. KEY POINTS: • Multiple pharmaceuticals were removed by stable microbial communities. • Microbial key players of five main pharmaceuticals were identified.

Impact of anaerobic zone on biodegradation of micropollutants: Comparison of micropollutants' removal efficiencies in lab-scale anaerobic bioreactor and in full-scale anaerobic zone

Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation.

Differential biotransformation of micropollutants in conventional activated sludge and up-flow anaerobic sludge blanket processes

Removal characteristics of 53 micropollutants during ozonation, chlorination, and UV/H 2 O 2 processes used in drinking water treatment plant

Micropollutants in Wastewater: Fate and Removal Processes

Unraveling the potential of a combined nitritation-anammox biomass towards the biodegradation of pharmaceutically active compounds

Biodegradation of organic micropollutants by anoxic denitrification: Roles of extracellular polymeric substance adsorption, enzyme catalysis, and reactive oxygen species oxidation

Entry pathways determined the effects of MPs on sludge anaerobic digestion system: The views of methane production and antibiotic resistance genes fates

Fate, Elimination, and Simulation of Low-Molecular-Weight Micropollutants in Powdered Activated Carbon–Assisted Fertiliser-Drawn Osmotic Membrane Bioreactor

Removal of organic micropollutants in biologically active filters: A systematic quantitative review of key influencing factors

Study of anaerobic biodegradation of pharmaceuticals and personal care products: application of batch tests

Fate of Bulk Organic Matter, Nitrogen, and Pharmaceutically Active Compounds in Batch Experiments Simulating Soil Aquifer Treatment (SAT) Using Primary Effluent

Micropollutant Removal Efficiency of Advanced Wastewater Treatment Plants: A Systematic Review

The impacts of biodegradable and non-biodegradable microplastic on the performance and microbial community characterization of aerobic granular sludge

Analyzing microbial communities and their biodegradation of multiple pharmaceuticals in membrane bioreactors

Impacts of Polylactic Acid Microplastics on Performance and Microbial Dynamics in Activated Sludge System

Insights into soil autotrophic ammonium oxidization under microplastics stress: Crossroads of nitrification, comammox, anammox and Feammox

Elimination of Micropollutants in Activated Sludge Reactors with a Special Focus on the Effect of Biomass Concentration

Influence of microplastics on microbial anaerobic detoxification of chlorophenols

Removal of Pharmaceuticals and Personal Care Products during Water Recycling: Microbial Community Structure and Effects of Substrate Concentration

Influence of microplastic contamination on the dissipation of endocrine disrupting chemicals in soil environment